Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD

Prevention of Pregnancy Clinical Trial

Official title:
Study of the VeraCept Intrauterine Device for Long Acting Reversible Contraception

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the safety and effectiveness of the VeraCept Low Dose Intrauterine Copper Contraceptive compared to the standard T shaped copper IUD, the TCu380.

Clinical Trial Description

This is a prospective, randomized, subject-blinded, two arm controlled study of the Safety, Feasibility and Effectiveness of the VeraCept low-dose intrauterine copper contraceptive as compared to a concurrently controlled, commercially available standard copper "T" IUD (TCu380). ;

Study Design

Related Conditions & MeSH terms

Prevention of Pregnancy

Clinical Trial Details

NCT number	NCT02167763
Study type	Interventional
Source	Sebela Pharmaceuticals Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	November 2013
Completion date	December 31, 2017

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00932321` - Study of Safety and Efficacy of an Oral Contraceptive	Phase 3
	Completed	`NCT03091595` - E4/DRSP Ovarian Function Inhibition Study	Phase 2